<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art560.dtd?><?SourceDTD.Version 5.6.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_ISCI743 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEgr5 jpg ?><?FILEgr6 jpg ?><?FILEfx1 jpg ?><?FILEmmc1 pdf ?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">iScience</journal-id><journal-id journal-id-type="iso-abbrev">iScience</journal-id><journal-title-group><journal-title>iScience</journal-title></journal-title-group><issn pub-type="epub">2589-0042</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6908994</article-id><article-id pub-id-type="publisher-id">S2589-0042(19)30488-2</article-id><article-id pub-id-type="doi">10.1016/j.isci.2019.11.037</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Divergent Biosynthesis of <italic>C</italic>-Nucleoside Minimycin and Indigoidine in Bacteria</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Kong</surname><given-names>Liyuan</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn1" ref-type="fn">4</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Xu</surname><given-names>Gudan</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn1" ref-type="fn">4</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Liu</surname><given-names>Xiaoqin</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn1" ref-type="fn">4</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>Wang</surname><given-names>Jingwen</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au5"><name><surname>Tang</surname><given-names>Zenglin</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au6"><name><surname>Cai</surname><given-names>You-Sheng</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au7"><name><surname>Shen</surname><given-names>Kun</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au8"><name><surname>Tao</surname><given-names>Weixin</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au9"><name><surname>Zheng</surname><given-names>Yu</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author" id="au10"><name><surname>Deng</surname><given-names>Zixin</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au11"><name><surname>Price</surname><given-names>Neil P.J.</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author" id="au12"><name><surname>Chen</surname><given-names>Wenqing</given-names></name><email>wqchen@whu.edu.cn</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn2" ref-type="fn">5</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, and School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China</aff><aff id="aff2"><label>2</label>State Key Laboratory of Food Nutrition and Safety, Tianjin Engineering Research Center of Microbial Metabolism and Fermentation Process Control, and College of Biotechnology, Tianjin University of Science &#x00026; Technology, Tianjin 300457, China</aff><aff id="aff3"><label>3</label>Agricultural Research Service, US Department of Agriculture, National Center for Agricultural Utilization Research, Peoria, IL, USA</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author <email>wqchen@whu.edu.cn</email></corresp><fn id="fn1"><label>4</label><p id="ntpara0010">These authors contributed equally</p></fn><fn id="fn2"><label>5</label><p id="ntpara0015">Lead Contact</p></fn></author-notes><pub-date pub-type="pmc-release"><day>25</day><month>11</month><year>2019</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><day>20</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>25</day><month>11</month><year>2019</year></pub-date><volume>22</volume><fpage>430</fpage><lpage>440</lpage><history><date date-type="received"><day>11</day><month>9</month><year>2019</year></date><date date-type="rev-recd"><day>13</day><month>11</month><year>2019</year></date><date date-type="accepted"><day>19</day><month>11</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 The Author(s)</copyright-statement><copyright-year>2019</copyright-year><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><title>Summary</title><p>Minimycin (MIN) is a <italic>C</italic>-nucleoside antibiotic structurally related to pseudouridine, and indigoidine is a naturally occurring blue pigment produced by diverse bacteria. Although MIN and indigoidine have been known for decades, the logic underlying the divergent biosynthesis of these interesting molecules has been obscure. Here, we report the identification of a minimal 5-gene cluster (<italic>min</italic>) essential for MIN biosynthesis. We demonstrated that a non-ribosomal peptide synthetase (MinA) governs &#x0201c;the switch&#x0201d; for the divergent biosynthesis of MIN and the cryptic indigoidine. We also demonstrated that MinC<sub>N</sub> (the <italic>N</italic>-terminal phosphatase domain of MinC), MinD (uracil phosphoribosyltransferase), and MinT (transporter) function together as the safeguard enzymes, which collaboratively constitute an unusual self-resistance system. Finally, we provided evidence that MinD, utilizing an unprecedented substrate-competition strategy for self-resistance of the producer cell, maintains competition advantage over the active molecule MIN-5&#x02032;-monophosphate by increasing the UMP pool <italic>in&#x000a0;vivo</italic>. These findings greatly expand our knowledge regarding natural product biosynthesis.</p></abstract><abstract abstract-type="graphical" id="abs0015"><title>Graphical Abstract</title><fig id="undfig1" position="anchor"><graphic xlink:href="fx1"/></fig></abstract><abstract abstract-type="author-highlights" id="abs0020"><title>Highlights</title><p><list list-type="simple" id="ulist0010"><list-item id="u0010"><label>&#x02022;</label><p id="p0010">A minimal 5-gene cluster (<italic>min</italic>) is essential for minimycin biosynthesis</p></list-item><list-item id="u0015"><label>&#x02022;</label><p id="p0015">Divergent biosynthesis of minimycin and indigoidine is mediated by an NRPS enzyme</p></list-item><list-item id="u0020"><label>&#x02022;</label><p id="p0020">A cascade of three safeguard enzymes constitutes the unusual self-resistance system</p></list-item><list-item id="u0025"><label>&#x02022;</label><p id="p0025">MinD functions as the key safeguard enzyme by increasing the UMP pool <italic>in&#x000a0;vivo</italic></p></list-item></list></p></abstract><abstract abstract-type="teaser" id="abs0025"><p>Biotechnology; Microbial Biotechnology; Systems Biology</p></abstract><kwd-group id="kwrds0010"><title>Subject Areas</title><kwd>Biotechnology</kwd><kwd>Microbial Biotechnology</kwd><kwd>Systems Biology</kwd></kwd-group></article-meta><notes><p id="misc0010">Published: December 20, 2019</p></notes></front><body><sec id="sec1"><title>Introduction</title><p id="p0030">The <italic>C</italic>-nucleoside antibiotics (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>) constitute an important sub-group of microbial natural products with unusual structural features and diverse biological activities (<xref rid="bib7" ref-type="bibr">Isono, 1988</xref>, <xref rid="bib15" ref-type="bibr">Maffioli et&#x000a0;al., 2017</xref>). Their biosynthesis generally follows a succinct logic, with sequential modifications of simple precursors originating from primary metabolism (<xref rid="bib6" ref-type="bibr">Hong et&#x000a0;al., 2019</xref>, <xref rid="bib7" ref-type="bibr">Isono, 1988</xref>, <xref rid="bib21" ref-type="bibr">Palmu et&#x000a0;al., 2017</xref>, <xref rid="bib27" ref-type="bibr">Sosio et&#x000a0;al., 2018</xref>, <xref rid="bib32" ref-type="bibr">Wang et&#x000a0;al., 2019</xref>). Less typically, minimycin (MIN, also called oxazinomycin) is produced by diverse bacterial strains, either <italic>Streptomyces</italic> sp. or <italic>Pseudomonas</italic> sp., and shows prominent antimicrobial activities against both Gram-positive and Gram-negative bacteria (<xref rid="bib12" ref-type="bibr">Kusakabe et&#x000a0;al., 1972</xref>, <xref rid="bib31" ref-type="bibr">Tymiak et&#x000a0;al., 1984</xref>). It has also demonstrated antitumor activity against transplantable tumors (<xref rid="bib12" ref-type="bibr">Kusakabe et&#x000a0;al., 1972</xref>).<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Chemical Structures of Representative <italic>C-</italic>Nucleoside Antibiotics and Indigoidine</p><p>Several <italic>C-</italic>nucleoside antibiotics (MIN-showdomycin, group I; pyrazofurin-formycin, group II; malayamycin-pseudouridimycin, group III) shown are deduced to employ distinct enzymatic logics for the assembly of the <italic>C-</italic>glycosidic bond. The structure of indigoidine is highlighted in blue to represent its intrinsic color.</p></caption><graphic xlink:href="gr1"/></fig></p><p id="p0035">MIN is structurally similar to pseudouridine, a modified nucleoside that is found abundantly in tRNA (<xref rid="bib13" ref-type="bibr">Li et&#x000a0;al., 2016</xref>). The MIN molecule has a unique structural feature in which a 1,3-oxazine 2,4-dione ring and a ribosyl sugar are linked via a <italic>C</italic>-glycoside bond (<xref rid="bib25" ref-type="bibr">Sasaki et&#x000a0;al., 1972</xref>) (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>). Previous metabolic labeling studies have shown that the ribosyl portion of MIN derives directly from D-ribose (<xref rid="bib8" ref-type="bibr">Isono and Suhadolnik, 1975</xref>, <xref rid="bib9" ref-type="bibr">Isono and Suhadolnik, 1977</xref>), and C-6, C-5, and C-4 of the oxazine ring arise from the corresponding C-3, C-4, and C-5 of L-glutamate (<xref rid="bib9" ref-type="bibr">Isono and Suhadolnik, 1977</xref>). Metabolic feeding experiments by Isono et&#x000a0;al. showed that the C-2 of MIN is derived from carbon dioxide (<xref rid="bib8" ref-type="bibr">Isono and Suhadolnik, 1975</xref>). Concomitant chemical synthesis of MIN was also achieved, with the finding that the synthetic form of MIN shares identical biological features with that from microbial source (<xref rid="bib2" ref-type="bibr">De Bernardo and Weigele, 1977</xref>).</p><p id="p0040">Indigoidine (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>) is a bipyridyl pigment that was first documented as a microbial natural product in the 1960s (<xref rid="bib11" ref-type="bibr">Kuhn et&#x000a0;al., 1965</xref>), and later discovered to be produced by surprisingly diverse microbes (<xref rid="bib5" ref-type="bibr">Heumann et&#x000a0;al., 1968</xref>, <xref rid="bib28" ref-type="bibr">Starr et&#x000a0;al., 1966</xref>). The indigoidine biosynthetic gene cluster was initially reported from <italic>Dickeya dadantii</italic> (formerly known as <italic>Erwinia chrysanthemi</italic>), and it was revealed that it has important roles in pathogenicity and self-resistance to oxidative stress (<xref rid="bib23" ref-type="bibr">Reverchon et&#x000a0;al., 2002</xref>). The gene for indigoidine biosynthesis was later identified from diverse <italic>Streptomyces</italic> strains (<xref rid="bib18" ref-type="bibr">Novakova et&#x000a0;al., 2010</xref>, <xref rid="bib20" ref-type="bibr">Pait et&#x000a0;al., 2017</xref>, <xref rid="bib35" ref-type="bibr">Yu et&#x000a0;al., 2013</xref>). A single module non-ribosomal peptide synthetase (NRPS), which selectively recognizes L-glutamine as the starter substrate, was necessary for indigoidine biosynthesis (<xref rid="bib1" ref-type="bibr">Brown et&#x000a0;al., 2017</xref>, <xref rid="bib30" ref-type="bibr">Takahashi et&#x000a0;al., 2007</xref>). The indigoidine NRPS gene was subsequently engineered as a promising tool for synthetic biology purposes, either for natural product discovery (<xref rid="bib19" ref-type="bibr">Olano et&#x000a0;al., 2014</xref>) or as a reporter system (<xref rid="bib16" ref-type="bibr">Muller et&#x000a0;al., 2012</xref>, <xref rid="bib24" ref-type="bibr">Rezuchova et&#x000a0;al., 2018</xref>, <xref rid="bib34" ref-type="bibr">Xie et&#x000a0;al., 2017</xref>). More recently, Ankanahalli et&#x000a0;al. have created a transgenic blue rose by introduction of a bacterial indigoidine biosynthesis gene (<italic>idgS</italic>) and a phosphopantetheinyl transferase gene (<italic>sfp</italic>) from surfactin biosynthesis (<xref rid="bib17" ref-type="bibr">Nanjaraj Urs et&#x000a0;al., 2019</xref>).</p><p id="p0045">In the present study, we address the biosynthesis of <italic>C</italic>-nucleoside MIN and indigoidine in <italic>Streptomyces hygroscopicus</italic> JCM 4712. We report that a minimal 5-gene cluster is essential for MIN biosynthesis and show that the divergent biosynthesis of MIN and indigoidine is mediated by an NRPS, MinA. Moreover, we reveal that the <italic>N-</italic>terminal phosphatase domain of MinC (called MinC<sub>N</sub>), the MinD uracil phosphoribosyltransferase, and the MinT transporter are safeguard enzymes, which collaboratively constitute an unusual self-resistance system, in which MinD likely employs an unprecedented substrate-competition strategy for self-resistance by increasing the UMP pool <italic>in&#x000a0;vivo</italic>. Our deciphering of the <italic>C</italic>-nucleoside MIN pathway expands current understanding regarding natural product biosynthesis and self-resistance.</p></sec><sec id="sec2"><title>Results and Discussion</title><sec id="sec2.1"><title>Identification of MIN Biosynthetic Gene Cluster from <italic>S.&#x000a0;hygroscopicus</italic> JCM 4712</title><p id="p0050">To identify the gene cluster responsible for MIN biosynthesis, the genome of <italic>S.&#x000a0;hygroscopicus</italic> JCM 4712 was sequenced using the Illumina Hiseq 4000 method, which renders 8.8-Mb data (G&#x000a0;+ C content 70.31%) after assembly of clean reads. MIN contains a <italic>C</italic>-glycosidic bond that is structurally similar to that of pseudouridine and showdomycin (<xref rid="bib21" ref-type="bibr">Palmu et&#x000a0;al., 2017</xref>) (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>), implying that they should employ similar enzymatic logic for <italic>C</italic>-glycosidic bond formation. We therefore utilize pseudouridine 5&#x02032;-phosphate glycosidase YeiN (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-p:CAQ32570.1" id="intref0010">CAQ32570.1</ext-link>) and <italic>C</italic>-glycosynthase SdmA (GenBank: KKZ73237.1) as query sequences to conduct individual BLASTP analysis, leading to the discovery of two homologs ORF5178 (designated as MinB, 46%/49% identities to YeiN/SdmA) (<xref rid="tbl1" ref-type="table">Table 1</xref>) and ORF3816 (46%/46% identities to YeiN/SdmA) from the genome of <italic>S.&#x000a0;hygroscopicus</italic> JCM 4712 (GenBank: MN397911). On the genomic region surrounding <italic>minB</italic> is a closely linked gene coding for a non-ribosomal peptide synthetase (MinA) (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>A). The <italic>orf3816</italic> gene is linked with a kinase gene (GenBank: MN397911), which is identical to the YeiN-YeiC cascade for the pseudouridine metabolic pathway in <italic>E.&#x000a0;coli</italic> (<xref rid="bib22" ref-type="bibr">Preumont et&#x000a0;al., 2008</xref>). These data suggest that the target region (<italic>min</italic>) covering <italic>minA</italic> and <italic>minB</italic> is likely to be involved in MIN biosynthesis.<table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>Deduced Functions of the Open Reading Frames in the <italic>min</italic> Gene Cluster</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Protein</th><th>aa</th><th>Protein Function</th><th>Homolog, Origin</th><th>Identity, Similarity (%)</th><th>Accession No.</th></tr></thead><tbody><tr><td>MinR</td><td align="char">211</td><td>FadR family transcriptional regulator</td><td>SAMN05444521_6508, <italic>Streptomyces</italic> sp. 3124.6</td><td>87, 94</td><td>SHI26670</td></tr><tr><td>MinT</td><td align="char">419</td><td>MFS transporter</td><td>SAMN05444521_6509, <italic>Streptomyces</italic> sp. 3124.6</td><td>79, 85</td><td>SHI26674</td></tr><tr><td>MinA</td><td align="char">1379</td><td>NRPS(A-Ox-T-TE-Tau)</td><td>IndC, <italic>S.&#x000a0;chromofuscus</italic> ATCC 49982</td><td>74, 82</td><td>AFV27434</td></tr><tr><td>MinB</td><td align="char">317</td><td><italic>C</italic>-glycosynthase</td><td>IndA, <italic>S.&#x000a0;chromofuscus</italic> ATCC 49982</td><td>88, 93</td><td>AFV27435</td></tr><tr><td>MinC</td><td align="char">613</td><td>HAD phosphatase and DUF4243 domain</td><td>IndB, <italic>S.&#x000a0;chromofuscus</italic> ATCC 49982</td><td>77, 84</td><td>AFV27436</td></tr><tr><td>MinD</td><td align="char">240</td><td>Uracil phosphoribosyltransferase</td><td>Orf2, <italic>S.&#x000a0;chromofuscus</italic> ATCC 49982</td><td>81, 90</td><td>AFV27437</td></tr></tbody></table></table-wrap><fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Genetic Organization and Investigation of the <italic>min</italic> Gene Cluster</p><p>(A) Genetic organization of the MIN gene cluster; A, adeylation domain; Ox, oxidase domain; T, thiolation domain; TE,&#x000a0;thioesterase domain; Tau, tautomerase domain.</p><p>(B) Bioassays of the metabolites produced by related recombinants of <italic>S.&#x000a0;coelicolor</italic> M1154. The indicator strain is <italic>Bacillus subtilis</italic>.</p><p>(C) HPLC analysis of the metabolites produced by related recombinants of <italic>S.&#x000a0;coelicolor</italic> M1154. Std, the authentic standard of MIN; pCHW301, the metabolites of the recombinant <italic>S.&#x000a0;coelicolor</italic> M1154 containing pCHW301; <italic>&#x00394;minA</italic>, the metabolites of the recombinant <italic>S.&#x000a0;coelicolor</italic> M1154 containing pCHW301<italic>&#x00394;minA</italic>, and other samples are correspondingly assigned; pSET152, the metabolites of the recombinant <italic>S.&#x000a0;coelicolor</italic> M1154 containing pSET152 as negative control. The aliphatic numbers correspond to those in the bioassay plate.</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figures S1&#x02013;S3</xref>; <xref rid="tbl1" ref-type="table">Tables 1</xref> and <xref rid="mmc1" ref-type="supplementary-material">S1&#x02013;S4</xref>.</p></caption><graphic xlink:href="gr2"/></fig></p><p id="p0055">To determine the identity of the <italic>min</italic> gene cluster, we directly cloned a ca. 11.2-kb region (likely housing the whole <italic>min</italic> gene cluster) using a two-step PCR strategy (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref>A; <xref rid="mmc1" ref-type="supplementary-material">Tables S1</xref> and <xref rid="mmc1" ref-type="supplementary-material">S2</xref>). After confirmation (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref>B), the resultant plasmid pCHW301 was transferred into <italic>Streptomyces coelicolor</italic> M1154 (<xref rid="bib4" ref-type="bibr">Gomez-Escribano and Bibb, 2014</xref>). The positive conjugants (<italic>S.&#x000a0;coelicolor</italic> M1154::pCHW301) were then fermented for metabolite analysis. A bioassay indicated that the samples of M1154::pCHW301 show apparent inhibition against the indicator strain <italic>Bacillus subtilis</italic>, but the negative control (<italic>S.&#x000a0;coelicolor</italic> M1154::pSET152) lacks related bioactivity (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref>C). High-performance liquid chromatography (HPLC) analysis showed that the sample of M1154::pCHW301 contains a new peak, which is absent from that of the negative control (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref>D). Further liquid chromatography-mass spectrometry (LC-MS) analysis shows that the LC peak is able to generate a characteristic [M&#x000a0;+ H]<sup>+</sup> ion at <italic>m/z</italic> 246.0609, with major fragment ions at <italic>m/z</italic> 155.9695, 210.1091, and 228.0699, fully consistent with the theoretical fragmentation pattern of MIN (<xref rid="mmc1" ref-type="supplementary-material">Figures S1</xref>E&#x02013;S1G).</p><p id="p0060">To confirm the identity of the target metabolite accumulated by M1154::pCHW301, it was HPLC purified for 1D and 2D NMR analysis. As anticipated, the 1D NMR data of the target metabolite are closely matched to those of MIN (<xref rid="mmc1" ref-type="supplementary-material">Figures S2</xref>A and S2B), and further detailed assignments of the compound as MIN are supported by <sup>1</sup>H-<sup>1</sup>H COSY (Correlation Spectroscopy) and HMBC (Heteronuclear Multiple Bond Correlation) spectra (<xref rid="mmc1" ref-type="supplementary-material">Figures S2</xref>C and S2D). Analysis of the COSY NMR data led to the identification of a single isolated proton spin system corresponding to the ribose moiety (C-5&#x02032;, C-4&#x02032;, C-3&#x02032;, C-2&#x02032;, and C-1&#x02032;), from which the relative configuration was determined based on the analysis of coupling constants. The connection between the ribose moiety and (2H)-1,3-oxazine-2,4-(3H)-dione subunit was deduced from HMBC correlations of H-6 with C-1&#x02032;; H-1&#x02032; with C-4 and C-6; and H-2&#x02032; with C-5 (<xref rid="mmc1" ref-type="supplementary-material">Table S3</xref>). Accordingly, the structure of the target metabolite was determined to be the same as that of MIN as shown. Taken together, these data demonstrate that the target gene cluster is responsible for the biosynthesis of MIN.</p></sec><sec id="sec2.2"><title>The Minimal 5-Gene (<italic>minTABCD</italic>) Cluster Is Essential for MIN Biosynthesis</title><p id="p0065"><italic>In silico</italic> analysis revealed that the target 11.2-kb region (included in pCHW301) containing six genes is deduced to be involved in MIN biosynthesis. MinR shows 87% identity to SAMN05444521_6508 of <italic>Streptomyces</italic> sp. 3124.6, which is likely a FadR family transcriptional regulator. The second gene, <italic>minT</italic>, codes for an MFS transporter with high homology (79% identity) to SAMN05444521_6509 of <italic>Streptomyces</italic> sp. 3124.6 (<xref rid="tbl1" ref-type="table">Table 1</xref>), which is proposed to transport the antibiotic out of the producer cell. The <italic>minA</italic> product displays significant homology (74% identities in total) to IndC, an NRPS protein from <italic>Streptomyces chromofuscus</italic> ATCC 49982, and the domain architectures of both enzymes are highly matched (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>).&#x000a0;MinB is shown to be homologous to IndA (pseudouridine-5&#x02032;-phosphate glycosidase) with 88% identities (<xref rid="tbl1" ref-type="table">Table 1</xref>). Moreover, <italic>in silico</italic> analysis shows that MinC possesses 77% identities to IndB of <italic>S.&#x000a0;chromofuscus</italic> ATCC 49982 (<xref rid="tbl1" ref-type="table">Table 1</xref>). Notably, <italic>minC</italic> encodes a 613-amino acid protein containing two domains, an <italic>N-</italic>terminal HAD phosphatase domain and the <italic>C-</italic>terminal DUF4243 domain with unassigned function. Concerning MinD, it shows 81% identity to Orf2 (uracil phosphoribosyltransferase) of <italic>S.&#x000a0;chromofuscus</italic> ATCC 49982 (<xref rid="tbl1" ref-type="table">Table 1</xref>).</p><p id="p0070">To precisely pinpoint the minimal gene cluster for MIN biosynthesis, we individually mutated the target genes by an <italic>in&#x000a0;vitro</italic> CRISPR-Cas9 system (<xref rid="bib14" ref-type="bibr">Liu et&#x000a0;al., 2015</xref>). After confirmation (<xref rid="mmc1" ref-type="supplementary-material">Figures S3</xref>A and S3B; <xref rid="mmc1" ref-type="supplementary-material">Tables S2</xref> and <xref rid="mmc1" ref-type="supplementary-material">S4</xref>), the pCHW301 variants were conjugated into <italic>S.&#x000a0;coelicolor</italic> M1154, and the resultant recombinants were fermented for further metabolite analysis. The antibacterial bioassay indicated that all the samples, with the exception for those of M1154::pCHW301 and M1154::pCHW301<italic>&#x00394;minR</italic>, lack bioactivities against the <italic>Bacillus subtilis</italic> indicator strain (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>B). Moreover, reverse-phase HPLC analysis indicated that the sample from M1154::pCHW301<italic>&#x00394;minR</italic> could also produce the distinctive peak for MIN (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>C), whose identity was further confirmed by LC-MS analysis (<xref rid="mmc1" ref-type="supplementary-material">Figures S3</xref>C&#x02013;S3F), suggesting that MIN biosynthesis is not under strict regulation by <italic>minR</italic> in <italic>S.&#x000a0;coelicolor</italic>. These data demonstrate that a minimal 5-gene cluster (<italic>minTABCD</italic>) is essential for the maintenance of MIN biosynthesis.</p></sec><sec id="sec2.3"><title>Reconstitution of the MinA-Mediated Pathway for Indigoidine Biosynthesis</title><p id="p0075">Bioinformatic analysis showed that MinA is a typical NRPS protein containing multiple A-Ox-T-TE-Tau domains (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S4</xref>A; <xref rid="tbl1" ref-type="table">Table 1</xref>). More surprisingly, MinA homologs had been previously characterized as the indigoidine synthetases (<xref rid="bib30" ref-type="bibr">Takahashi et&#x000a0;al., 2007</xref>) (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>A), and we were therefore curious about how this enzyme is utilized to build MIN. To evaluate the functional role of MinA, the <italic>minA</italic> sequence was optimized on the basis of <italic>E.&#x000a0;coli</italic> preference (<xref rid="mmc1" ref-type="supplementary-material">Table S5</xref>), and the resultant plasmid pET28a/<italic>minA*</italic> (*signifies the optimized sequence) was transferred into <italic>E.&#x000a0;coli</italic> for protein overexpression and metabolite analysis. As anticipated, the broth of the <italic>E.&#x000a0;coli</italic> recombinant showed a distinctive blue color (indigo) (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B), implicating the potential production of indigo dye. To further determine the identity of the blue pigment, a metabolite sample from the <italic>E.&#x000a0;coli</italic> pET28a/<italic>minA*</italic> was submitted for HPLC assessment, generating a characteristic peak that was absent from the <italic>E.&#x000a0;coli</italic> strain lacking <italic>minA</italic>* (negative control) (<xref rid="fig3" ref-type="fig">Figures 3</xref>B, <xref rid="mmc1" ref-type="supplementary-material">S4</xref>B, and S4C). Further LC-MS analysis indicated that the LC peak produces an [M&#x000a0;+ H]<sup>+</sup> ion at <italic>m/z</italic> 249.0615, and corresponding fragment ions at <italic>m/z</italic> 216.7811 and 231.9472, consistent with those of indigoidine (<xref rid="mmc1" ref-type="supplementary-material">Figures S4</xref>D and S4E). Hence, this demonstrated that the single NRPS (MinA)-mediated pathway is sufficient to support indigoidine biosynthesis.<fig id="fig3"><label>Figure&#x000a0;3</label><caption><p><italic>In&#x000a0;Vivo</italic> and <italic>In&#x000a0;Vitro</italic> Reconstitution of the MinA Mediated Assembly Line</p><p>(A) Schematic of the MinA-mediated assembly line for indigoidine biosynthesis.</p><p>(B) Engineered production of indigoidine in <italic>E.&#x000a0;coli</italic>. Top, the target metabolite (blue) produced by related strains. Bottom, HPLC analysis of the target metabolite indigoidine produced by related <italic>E.&#x000a0;coli</italic> strains. pET28a/<italic>indC</italic>, extracted metabolite of <italic>E.&#x000a0;coli</italic> BAP1 containing <italic>indC</italic> (indigoidine synthetase gene from <italic>S.&#x000a0;chromofuscus</italic> ATCC 49982) as positive control; pET28a/<italic>minA</italic>*, extracted metabolite of <italic>E.&#x000a0;coli</italic> BAP1 containing <italic>minA</italic>*; pET28a, extracted metabolite of <italic>E.&#x000a0;coli</italic> BAP1 containing pET28a as negative control.</p><p>(C) The extracted enzymatic products of the MinA reactions. Complete, the MinA reaction with all essential factors added; -Mg<sup>2+</sup>, the MinA reaction without adding exogenous Mg<sup>2+</sup>; -FMN, the MinA reaction without adding exogenous FMN; -L-Gln, the MinA reaction without L-glutamine added; -ATP, the MinA reaction without ATP added; -O<sub>2</sub>, the MinA reaction under N<sub>2</sub> atmosphere.</p><p>(D) HPLC analysis of the related MinA reactions. The characteristic [M&#x000a0;+ H]<sup>+</sup> ion of indigoidine was also indicated on this panel, and the information for related samples corresponds to that in panel C.</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figures S4</xref> and <xref rid="mmc1" ref-type="supplementary-material">S5</xref>; <xref rid="mmc1" ref-type="supplementary-material">Tables S1</xref> and <xref rid="mmc1" ref-type="supplementary-material">S5</xref>.</p></caption><graphic xlink:href="gr3"/></fig></p><p id="p0080">To reconstitute MinA activity <italic>in&#x000a0;vitro</italic>, we over-expressed and purified the MinA protein from <italic>E.&#x000a0;coli</italic>. The purified MinA shows bright yellow color (<xref rid="mmc1" ref-type="supplementary-material">Figures S4</xref>F and S4G), a typical feature of a flavin-dependent protein, as confirmed by LC-MS analysis (<xref rid="mmc1" ref-type="supplementary-material">Figures S4</xref>H and S4I). Enzymatic assays with the recombinant MinA produced an obvious blue color, implicating the production of indigoidine (<xref rid="fig3" ref-type="fig">Figures 3</xref>C and 3D), whose identity is further confirmed by LC-MS analysis (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S4</xref>J). The <italic>in&#x000a0;vitro</italic> reaction without enzyme added (negative control) was unable to generate the blue-colored product, and the enzyme reactions in the absence of L-glutamine, ATP, or O<sub>2</sub> also generate similar negative results (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>D). Furthermore, the purified MinA has only partial activity without an exogenous addition of FMN or Mg<sup>2+</sup> (<xref rid="fig3" ref-type="fig">Figures 3</xref>D and <xref rid="mmc1" ref-type="supplementary-material">S4</xref>K&#x02013;S4M) and indicates the preference to relative low temperatures (18&#x000b0;C of all temperatures tested) (<xref rid="mmc1" ref-type="supplementary-material">Figures S4</xref>N&#x02013;S4P and S4R). Subsequently, we tested the substrate flexibility for MinA against the unnatural isomer D-glutamine with negative result (<xref rid="mmc1" ref-type="supplementary-material">Figures S4</xref>Q and S4R). These combined data substantially established that divergent biosynthesis of MIN and indigoidine is mediated by the NRPS (MinA) pathway, in which the compound <bold>1</bold> is likely converted to indigoidine via a non-enzymatic spontaneous reaction.</p><p id="p0085">The potential pathways mediated by MinA homologs, as shown by <italic>in silico</italic> analysis, are actually more widely distributed than we initially imagined. In addition, there is also a high degree of diversity at the genetic level (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S5</xref>). Earlier studies reported that indigoidine production affects the pathogenicity of the plant pathogen <italic>Dickeya dadantii</italic> (<xref rid="bib23" ref-type="bibr">Reverchon et&#x000a0;al., 2002</xref>). In the present study, we tentatively propose that this bacterium could perform its pathogenic role by the coupled production of a potential MIN-related compound (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S5</xref>), and it is of great interest for future study to elucidate such pathogenic mechanism at the molecular level.</p></sec><sec id="sec2.4"><title>MinC<sub>N</sub> Is Responsible for the Final Dephosphorylation Step, and MinD Functions as a Uracil Phosphoribosyltransferase (UPRTase)</title><p id="p0090"><italic>In silico</italic> analysis showed that MinC is a two-domain enzyme, consisting of an <italic>N-</italic>terminal phosphatase domain and a <italic>C-</italic>terminal domain of undefined function (we have not yet determine the characteristic properties of MinC<sub>C</sub> in the present study) (<xref rid="mmc1" ref-type="supplementary-material">Figures S6</xref>A and S6B), and that in some cases these are separated into two independent proteins (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S6</xref>A). To determine if MinC<sub>N</sub> catalyzes the final dephosphorylation step (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>A), we over-expressed and purified the protein from <italic>E.&#x000a0;coli</italic> to near homogeneity (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S6</xref>C). This was assayed <italic>in&#x000a0;vitro</italic> against the substrate MIN-MP, which is supplied by the Udk (uridine kinase from <italic>Bacillus subtilis</italic>, GenBank: QBJ70019.1) (<xref rid="mmc1" ref-type="supplementary-material">Table S6</xref>)-catalyzed reaction (<xref rid="mmc1" ref-type="supplementary-material">Figures S6</xref>D&#x02013;S6H). LC-MS analysis of the <italic>in&#x000a0;vitro</italic> reaction products indicated that the MinC<sub>N</sub> reaction is capable of generating a characteristic [M&#x000a0;+ H]<sup>+</sup> ion at <italic>m/z</italic> 246.0601, with major fragment ions at <italic>m/z</italic> 155.9384, 210.1541, and 228.0651, consistent with those of the authentic MIN standard (<xref rid="fig4" ref-type="fig">Figures 4</xref>B and <xref rid="mmc1" ref-type="supplementary-material">S6</xref>I&#x02013;S6K). This characteristic MIN peak was absent from the reaction without MinC<sub>N</sub> added (<xref rid="fig4" ref-type="fig">Figures 4</xref>B and <xref rid="mmc1" ref-type="supplementary-material">S6</xref>L). Hence, these data support the hypothesis that MinC<sub>N</sub> is responsible for the final dephosphorylation step during MIN biosynthesis.<fig id="fig4"><label>Figure&#x000a0;4</label><caption><p>Functional Characterization of MinC<sub>N</sub><italic>/</italic>MinD as Phosphatase/UPRTase</p><p>(A) Schematic of MinC<sub>N</sub>-catalyzed reaction. Udk, uridine kinase (GenBank: QBJ70019.1) from <italic>Bacillus subtilis</italic>; MIN-5&#x02032;-MP, MIN-5&#x02032;-monophosphate.</p><p>(B) LC-HRMS analysis of the Udk/MinC<sub>N</sub> reactions. MIN Std, the authentic standard of MIN;&#x000a0;+Udk, the Udk catalyzed reaction to form MIN-MP; -Udk, the reaction without Udk added as negative control; (+Udk)+MinC<sub>N</sub>, the Udk reaction, proceeded for 4 h, with further addition of MinC<sub>N</sub> for another 1 h; (+Udk)-MinC<sub>N</sub>, the Udk reaction (proceeded for 4 h) without further addition of MinC<sub>N</sub> (also incubated for another 1 h). The characteristic [M&#x000a0;+ H]<sup>+</sup> ions of MIN and MIN-MP are indicated as well in this panel for related peaks.</p><p>(C) Schematic of MinD-catalyzed reaction. PRPP, phosphoribosyl pyrophosphate.</p><p>(D) HPLC traces of the MinD reactions. Uracil Std, the authentic standard of uracil; UMP Std, the authentic standard of UMP;&#x000a0;+MinD, the MinD reaction using uracil and PRPP as substrates; -MinD, the reaction without MinD added as negative control. The characteristic [M&#x000a0;+ H]<sup>+</sup> ions of UMP/uracil are also indicated in this panel.</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figures S6</xref> and <xref rid="mmc1" ref-type="supplementary-material">S7</xref>; <xref rid="mmc1" ref-type="supplementary-material">Tables S1</xref> and <xref rid="mmc1" ref-type="supplementary-material">S6</xref>.</p></caption><graphic xlink:href="gr4"/></fig></p><p id="p0095">Bioinformatic analysis suggested that <italic>minD</italic> encodes an UPRTase, which are generally involved in the pyrimidine salvage pathway by catalyzing the reaction between uracil and phosphoribosylpyrophate (PRPP) to regenerate UMP (<xref rid="bib26" ref-type="bibr">Singh et&#x000a0;al., 2015</xref>) (<xref rid="fig4" ref-type="fig">Figures 4</xref>C and <xref rid="mmc1" ref-type="supplementary-material">S7</xref>A). To investigate the enzymatic role of MinD, it was over-expressed and purified from <italic>E.&#x000a0;coli</italic> (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S7</xref>B), and the corresponding activity was determined <italic>in&#x000a0;vitro</italic>. As anticipated, HPLC analysis showed that the MinD-catalyzed reaction could generate a peak for UMP, corresponding to an authentic standard, which was absent from the negative control (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>D). Further LC-MS analysis indicated that the target peak gave rise to a characteristic [M&#x000a0;+ H]<sup>+</sup> ion for UMP at <italic>m/z</italic> 325.0428, and main fragment ions at <italic>m/z</italic> 212.9202 and 227.0645, completely consistent with those of the UMP authentic standard (<xref rid="mmc1" ref-type="supplementary-material">Figures S7</xref>C&#x02013;S7E). These results establish that MinD functions as an UPRTase for the synthesis of UMP.</p></sec><sec id="sec2.5"><title>Divergent Biosynthesis of MIN and Indigoidine Is Mediated by an NRPS-Associated Assembly Line</title><p id="p0100">Previous isotopic feeding experiments had showed that L-glutamate is incorporated into the oxazine ring of MIN (<xref rid="bib9" ref-type="bibr">Isono and Suhadolnik, 1977</xref>, <xref rid="bib29" ref-type="bibr">Suhadolnik and Reichenbach, 1981</xref>), whereas its ribosyl moiety is from D-ribose (<xref rid="bib8" ref-type="bibr">Isono and Suhadolnik, 1975</xref>). In the present work, this mechanism is shown to be reasonable. MIN biosynthesis is confirmed to be initiated by MinA, which specifically selects L-glutamine as substrate, and the tethered amino acid is then dehydrogenated under strict and precise stereospecificity/regiospecificity at the C2-C3 positions by the oxidase domain (Ox domain). Subsequently, compound <bold>1</bold> is released by hydrolysis of the TE domain. Compound <bold>1</bold>, as a key branch intermediate, is proposed to be converted to indigoidine by a spontaneous oxidative coupling reaction (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>). Simultaneously, this intermediate could be tautomerized by the Tau domain to form <bold>2</bold>, which is modified by the MinB <italic>C-</italic>glycosynthase to produce <bold>3</bold>. Compound <bold>3</bold> subsequently undergoes an unusual oxidative deamination and recombination reaction catalyzed by MinC<sub>C</sub> to generate MIN-MP, which is followed by the final dephosphorylation step to complete MIN biosynthesis (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>). MinC<sub>C</sub> features a DUF4243 domain, which is also present in a Baeyer-Villiger oxidase AflY of the aflatoxin biosynthetic pathway (<xref rid="bib3" ref-type="bibr">Ehrlich et&#x000a0;al., 2005</xref>). In this respect, MinC<sub>C</sub> represents a novel type of Baeyer-Villiger oxidase catalyzing an unprecedented and intriguing oxidative deamination and recombination reaction, and relevant studies to investigate its enzymatic logic are now underway in our laboratory.<fig id="fig5"><label>Figure&#x000a0;5</label><caption><p>Proposed Pathway for the Biosynthesis of MIN and Indigoidine</p><p>Proposed pathway for the divergent biosynthesis of MIN and indigoidine. See also <xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S5</xref>.</p></caption><graphic xlink:href="gr5"/></fig></p><p id="p0105">Indigoidine is a well-established microbial metabolite known for over half a century. However, it has now been established for the first time that this pigment is actually associated with the co-production of the <italic>C</italic>-nucleoside MIN. Accordingly, it is possible that indigoidine biosynthesis from an increasing number of potential pathways may be associated with related unknown <italic>C-</italic>nucleoside molecules, because analogs of the MinA-MinB pair are in several cases concomitantly present in the specific gene clusters (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S5</xref>). L-glutamate is the common precursor for the aglycon of the <italic>C-</italic>nucleoside antibiotics, including MIN, formycin, pyrazofurin, and showdomycin (<xref rid="bib29" ref-type="bibr">Suhadolnik and Reichenbach, 1981</xref>), which until recently have been unexplored at the molecular level (<xref rid="bib6" ref-type="bibr">Hong et&#x000a0;al., 2019</xref>, <xref rid="bib21" ref-type="bibr">Palmu et&#x000a0;al., 2017</xref>, <xref rid="bib27" ref-type="bibr">Sosio et&#x000a0;al., 2018</xref>, <xref rid="bib32" ref-type="bibr">Wang et&#x000a0;al., 2019</xref>). Hence, we propose that further insight into the molecular logics underlying the biosynthesis of <italic>C-</italic>nucleoside antibiotics will identify diverse and unique enzymes for potential synthetic biology purposes.</p></sec><sec id="sec2.6"><title>MinC<sub>N,</sub> MinD, and MinT Functioning as the Safeguard Enzymes Constitute a Collaborative Self-Resistance System during MIN Biosynthesis</title><p id="p0110">The assignment of MinD as a UPRTase raises an interesting open question: what is the functional role of this enzyme during MIN biosynthesis? Considering the fact that MIN is also active against <italic>Streptomyces</italic>, we tentatively propose that it may play a key role in self-resistance during MIN biosynthesis by employing an unprecedented mechanism. We therefore introduced <italic>minD</italic> into <italic>S.&#x000a0;coelicolor</italic> M1154 to determine whether it mediates a safeguard role. In contrast to this expectation, the recombinant <italic>s</italic>train (M1154::pIB139<italic>minD</italic>) had no apparent resistance to MIN (10&#x000a0;&#x003bc;g/mL). Accordingly, we re-examined the MIN gene cluster and noticed that <italic>minC</italic><sub>N</sub> and <italic>minT</italic> are also potential contributors to the self-resistance system. To test the assumption, we individually introduced these two genes into <italic>S.&#x000a0;coelicolor</italic> M1154. However, neither gene was capable of supporting the growth of the corresponding <italic>S.&#x000a0;coelicolor</italic> M1154 recombinants in the presence of MIN (10&#x000a0;&#x003bc;g/mL, the minimal inhibitory concentration against <italic>S.&#x000a0;coelicolor</italic> M1154-derived negative controls in this study) (<xref rid="fig6" ref-type="fig">Figures 6</xref>A and 6B).<fig id="fig6"><label>Figure&#x000a0;6</label><caption><p>Proposed Self-Resistance Mechanism for the Biosynthesis of MIN</p><p>(A) Plate-grown experiments for <italic>S.&#x000a0;coelicolor</italic> M1154 recombinants containing related genes. For the first two plates, the recombinant incubated for 36&#x000a0;h (in the related square) corresponds to each other. For plates 2&#x02013;4, it means the identical plate that was incubated for different time (marker at the bottom of each plate); MIN (-), the MIN-negative plate; MIN (10&#x000a0;&#x003bc;g/mL), the plate containing MIN at a final concentation of 10&#x000a0;&#x003bc;g/mL. The recombinant in the related square corresponds to that described as below.</p><p>(B) Representational map for the plate-grown experiments. pIB139, <italic>S.&#x000a0;coelicolor</italic> M1154 containing the empty vector pIB139; pIB139D, <italic>S.&#x000a0;coelicolor</italic> M1154 containing pIB139/<italic>minD</italic>; pIB139T, <italic>S.&#x000a0;coelicolor</italic> M1154 containing pIB139/<italic>minT</italic>; pIB139C<sub>N</sub>, <italic>S.&#x000a0;coelicolor</italic> M1154 containing pIB139/<italic>minC</italic><sub>N</sub>; pIB139DT, <italic>S.&#x000a0;coelicolor</italic> M1154 containing pIB139/<italic>minDT</italic>; pIB139DC<sub>N</sub>, <italic>S.&#x000a0;coelicolor</italic> M1154 containing pIB139/<italic>minDC</italic><sub>N</sub>; pIB139TC<sub>N</sub>, <italic>S.&#x000a0;coelicolor</italic> M1154 containing pIB139/<italic>minTC</italic><sub>N</sub>; pIB139DTC<sub>N</sub>, <italic>S.&#x000a0;coelicolor</italic> M1154 containing pIB139/<italic>minDTC</italic><sub>N</sub>.</p><p>(C) The relative abundance of the UMP concentrations <italic>in&#x000a0;vivo</italic> for the strains at different growth stages (48 and 72 h). pSET152, the sample of <italic>S.&#x000a0;coelicolor</italic> M1154::pSET152 (blue); pCHW301, the sample of <italic>S.&#x000a0;coelicolor</italic> M1154::pCHW301 (red); &#x0201c;RA&#x0201d; denotes relative abundance. Data are represented as mean&#x000a0;&#x000b1; SEM.</p><p>(D) Proposed collaborative self-resistance system during MIN biosynthesis. Three enzymes, including MinC<sub>N</sub>, MinT, and MinD, collaborate to fulfill the mission of self-resistance during MIN biosynthesis, and MinD, acting as the key safeguard enzyme, employs an unprecedented strategy of substrate competition to achieve self-resistance during MIN biosynthesis.</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S7</xref> and <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>.</p></caption><graphic xlink:href="gr6"/></fig></p><p id="p0115">These results suggested that some combination of <italic>minC</italic><sub>N</sub>, <italic>minD</italic>, and <italic>minT</italic> may collaborate to fulfill the self-resistance role, and we accordingly introduced these different combinations into <italic>S.&#x000a0;coelicolor</italic> M1154. Notably, several of these combinations are able to support the effective growth of the corresponding <italic>S.&#x000a0;coelicolor</italic> M1154 recombinants in the presence of MIN, whereas the introduced single <italic>minC</italic><sub>N</sub>, <italic>minD</italic>, or <italic>minT</italic> could not maintain the apparent growth of the related recombinants. It was also observed that <italic>minD</italic> has a greater contribution to the self-resistance system, and the combination (containing <italic>minC</italic><sub>N</sub>, <italic>minD</italic>, and <italic>minT</italic>) could maintain the optimal growth status for the counterpart recombinant (<xref rid="fig6" ref-type="fig">Figures 6</xref>A and 6B). Together, these data demonstrate that <italic>minD,</italic> in collaboration with <italic>minC</italic><sub>N</sub> and <italic>minT,</italic> determines the functional role <italic>in&#x000a0;vivo</italic> constituting the self-resistance system during MIN biosynthesis.</p></sec><sec id="sec2.7"><title>Biosynthesis of MIN Employs a Substrate-Competition Strategy for Self-Resistance</title><p id="p0120">A further relevant question is how MIN executes its inhibitory role <italic>in&#x000a0;vivo</italic>? We propose that similar to many other nucleoside analogs (<xref rid="bib10" ref-type="bibr">Jordheim et&#x000a0;al., 2013</xref>), the phosphorylated form (MIN-MP) of MIN functions as the active inhibitory molecule. This is also supported by the discovery of kinases (from <italic>S.&#x000a0;coelicolor</italic> M1154 and <italic>Bacillus subtilis</italic>) capable of recognizing MIN as substrates (<xref rid="mmc1" ref-type="supplementary-material">Figures S6</xref>C&#x02013;S6H), and the fact that MinD (UPRTase) may function as a safeguard enzyme by enhancing the <italic>in&#x000a0;vivo</italic> UMP pool of microbial cells. To test this suggestion, we conducted bioassays using <italic>Bacillus subtilis</italic> as an indicator strain by exogenous addition of uridine and MIN at different concentration ratios. This strain showed resistance to MIN in the co-presence of relative high concentration of uridine (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S7</xref>F), implying that uridine, which is efficiently metabolized to UMP <italic>in&#x000a0;vivo</italic>, is capable of partly alleviating the inhibition of MIN. Moreover, the <italic>in&#x000a0;vivo</italic> UMP concentrations for the <italic>S.&#x000a0;coelicolor</italic> M1154 recombinants, as determined by LC-high-resolution MS (HRMS), are considerably higher than those of the negative control (<italic>S.&#x000a0;coelicolor</italic> M1154::pSET152) (<xref rid="fig6" ref-type="fig">Figures 6</xref>C and <xref rid="mmc1" ref-type="supplementary-material">S7</xref>G), providing further support for the self-resistance model employed in MIN biosynthesis. In contrast, the <italic>in&#x000a0;vivo</italic> MIN-MP (the active form of MIN), as indicated by LC-HRMS, is undetectable due to the relatively much lower concentration (if compared with that of UMP) (<xref rid="mmc1" ref-type="supplementary-material">Figures S7</xref>H and S7I). These data support the hypothesis that the inhibitory role of MIN is attenuated by UMP by an unprecedented substrate-competition mechanism.</p><p id="p0125">Biosynthetic bacteria have evolved several strategies for self-resistance during natural product production, often transporting the metabolite out of the producer cell upon its synthesis, or by modification of natural products or the target site (<xref rid="bib33" ref-type="bibr">Wencewicz, 2019</xref>). The substrate-competition strategy for self-resistance presented here is, to the best of our knowledge, unique, but it may be broadly exploited for microbial natural products biosynthesis. In this self-resistance system, the active inhibitory molecule MIN-MP is immediately dephosphorylated to form the end product MIN, most of which will be promptly transported out of the producer cells. MinD, therefore, functions as a safeguard enzyme that responds to sub-inhibitory concentrations of MIN-MP by increasing the UMP pool <italic>in&#x000a0;vivo</italic>, thereby achieving the self-resistance for the producer cell (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>D).</p></sec><sec id="sec2.8"><title>Limitations of the Study</title><p id="p0130">In this study, we have uncovered that divergent biosynthesis of MIN and indigoidine is mediated by an NRPS enzyme and have demonstrated that an unprecedented collaborative self-resistance system is employed for MIN biosynthesis. However, the precise mechanism of how MIN executes its inhibitory role will require further study. Further studies will also be required to understand the enzymatic formation of the oxazine ring substituent of MIN.</p></sec></sec><sec id="sec3"><title>Methods</title><p id="p0135">All methods can be found in the accompanying <xref rid="mmc1" ref-type="supplementary-material">Transparent Methods supplemental file</xref>.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A.S.</given-names></name><name><surname>Robins</surname><given-names>K.J.</given-names></name><name><surname>Ackerley</surname><given-names>D.F.</given-names></name></person-group><article-title>A sensitive single-enzyme assay system using the non-ribosomal peptide synthetase BpsA for measurement of L-glutamine in biological samples</article-title><source>Sci. Rep.</source><volume>7</volume><year>2017</year><fpage>41745</fpage><pub-id pub-id-type="pmid">28139746</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>De Bernardo</surname><given-names>S.</given-names></name><name><surname>Weigele</surname><given-names>M.</given-names></name></person-group><article-title>Synthesis of oxazinomycin (minimycin)</article-title><source>J.&#x000a0;Org. Chem.</source><volume>42</volume><year>1977</year><fpage>109</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">830847</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Ehrlich</surname><given-names>K.C.</given-names></name><name><surname>Montalbano</surname><given-names>B.</given-names></name><name><surname>Boue</surname><given-names>S.M.</given-names></name><name><surname>Bhatnagar</surname><given-names>D.</given-names></name></person-group><article-title>An aflatoxin biosynthesis cluster gene encodes a novel oxidase required for conversion of versicolorin a to sterigmatocystin</article-title><source>Appl. Environ. Microbiol.</source><volume>71</volume><year>2005</year><fpage>8963</fpage><lpage>8965</lpage><pub-id pub-id-type="pmid">16332900</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Gomez-Escribano</surname><given-names>J.P.</given-names></name><name><surname>Bibb</surname><given-names>M.J.</given-names></name></person-group><article-title>Heterologous expression of natural product biosynthetic gene clusters in <italic>Streptomyces coelicolor</italic>: from genome mining to manipulation of biosynthetic pathways</article-title><source>J.&#x000a0;Ind. Microbiol. Biotechnol.</source><volume>41</volume><year>2014</year><fpage>425</fpage><lpage>431</lpage><pub-id pub-id-type="pmid">24096958</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Heumann</surname><given-names>W.</given-names></name><name><surname>Young</surname><given-names>D.</given-names></name><name><surname>Gottlich</surname><given-names>C.</given-names></name></person-group><article-title>Leucoindigoidine formation by an <italic>Arthrobacter</italic> species and its oxidation to indigoidine by other micro-organisms</article-title><source>Biochim. Biophys. Acta</source><volume>156</volume><year>1968</year><fpage>429</fpage><lpage>431</lpage><pub-id pub-id-type="pmid">4868094</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>H.</given-names></name><name><surname>Samborskyy</surname><given-names>M.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Leadlay</surname><given-names>P.F.</given-names></name></person-group><article-title><italic>C</italic>-nucleoside formation in the biosynthesis of the antifungal malayamycin A</article-title><source>Cell Chem. Biol.</source><volume>26</volume><year>2019</year><fpage>493</fpage><lpage>501.e5</lpage><pub-id pub-id-type="pmid">30713097</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Isono</surname><given-names>K.</given-names></name></person-group><article-title>Nucleoside antibiotics: structure, biological activity, and biosynthesis</article-title><source>J.&#x000a0;Antibiot. (Tokyo)</source><volume>41</volume><year>1988</year><fpage>1711</fpage><lpage>1739</lpage><pub-id pub-id-type="pmid">3061990</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Isono</surname><given-names>K.</given-names></name><name><surname>Suhadolnik</surname><given-names>R.J.</given-names></name></person-group><article-title>The biosynthesis of the nucleoside antibiotics: minimycin formation by <italic>Streptomyces hygroscopicus</italic></article-title><source>Ann. N. Y Acad. Sci.</source><volume>255</volume><year>1975</year><fpage>390</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">1059367</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Isono</surname><given-names>K.</given-names></name><name><surname>Suhadolnik</surname><given-names>R.J.</given-names></name></person-group><article-title>Biosynthesis of the <italic>C</italic>-nucleoside, minimycin: asymmetric incorporation of glutamate and acetate into the oxazine ring</article-title><source>J.&#x000a0;Antibiot. (Tokyo)</source><volume>30</volume><year>1977</year><fpage>272</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">863787</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Jordheim</surname><given-names>L.P.</given-names></name><name><surname>Durantel</surname><given-names>D.</given-names></name><name><surname>Zoulim</surname><given-names>F.</given-names></name><name><surname>Dumontet</surname><given-names>C.</given-names></name></person-group><article-title>Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases</article-title><source>Nat. Rev. Drug Discov.</source><volume>12</volume><year>2013</year><fpage>447</fpage><lpage>464</lpage><pub-id pub-id-type="pmid">23722347</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>R.</given-names></name><name><surname>Starr</surname><given-names>M.P.</given-names></name><name><surname>Kuhn</surname><given-names>D.A.</given-names></name><name><surname>Bauer</surname><given-names>H.</given-names></name><name><surname>Knackmuss</surname><given-names>H.J.</given-names></name></person-group><article-title>Indigoidine and other bacterial pigments related to 3,3'-Bipyridyl</article-title><source>Arch. Mikrobiol.</source><volume>51</volume><year>1965</year><fpage>71</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">14347925</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Kusakabe</surname><given-names>Y.</given-names></name><name><surname>Nagatsu</surname><given-names>J.</given-names></name><name><surname>Shibuya</surname><given-names>M.</given-names></name><name><surname>Kawaguchi</surname><given-names>O.</given-names></name><name><surname>Hirose</surname><given-names>C.</given-names></name></person-group><article-title>Minimycin, a new antibiotic</article-title><source>J.&#x000a0;Antibiot. (Tokyo)</source><volume>25</volume><year>1972</year><fpage>44</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">5010645</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.Y.</given-names></name><name><surname>Ma</surname><given-names>S.Q.</given-names></name><name><surname>Yi</surname><given-names>C.Q.</given-names></name></person-group><article-title>Pseudouridine: the fifth RNA nucleotide with renewed interests</article-title><source>Curr. Opin. Chem. Biol.</source><volume>33</volume><year>2016</year><fpage>108</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">27348156</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Tao</surname><given-names>W.</given-names></name><name><surname>Wen</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>A.</given-names></name><name><surname>Deng</surname><given-names>Z.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name></person-group><article-title><italic>In&#x000a0;Vitro</italic> CRISPR/Cas9 System for efficient targeted DNA editing</article-title><source>MBio</source><volume>6</volume><year>2015</year><comment>e01714&#x02013;01715</comment></element-citation></ref><ref id="bib15"><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Maffioli</surname><given-names>S.I.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Degen</surname><given-names>D.</given-names></name><name><surname>Carzaniga</surname><given-names>T.</given-names></name><name><surname>Del Gatto</surname><given-names>G.</given-names></name><name><surname>Serina</surname><given-names>S.</given-names></name><name><surname>Monciardini</surname><given-names>P.</given-names></name><name><surname>Mazzetti</surname><given-names>C.</given-names></name><name><surname>Guglierame</surname><given-names>P.</given-names></name><name><surname>Candiani</surname><given-names>G.</given-names></name></person-group><article-title>Antibacterial nucleoside-analog inhibitor of bacterial RNA polymerase</article-title><source>Cell</source><volume>169</volume><year>2017</year><fpage>1240</fpage><lpage>1248.e23</lpage><pub-id pub-id-type="pmid">28622509</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>M.</given-names></name><name><surname>Auslander</surname><given-names>S.</given-names></name><name><surname>Auslander</surname><given-names>D.</given-names></name><name><surname>Kemmer</surname><given-names>C.</given-names></name><name><surname>Fussenegger</surname><given-names>M.</given-names></name></person-group><article-title>A novel reporter system for bacterial and mammalian cells based on the non-ribosomal peptide indigoidine</article-title><source>Metab. Eng.</source><volume>14</volume><year>2012</year><fpage>325</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">22543310</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Nanjaraj Urs</surname><given-names>A.N.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Yuchi</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group><article-title>Cloning and expression of a nonribosomal peptide synthetase to generate blue rose</article-title><source>ACS Synth. Biol.</source><volume>8</volume><year>2019</year><fpage>1698</fpage><lpage>1704</lpage><pub-id pub-id-type="pmid">30216051</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Novakova</surname><given-names>R.</given-names></name><name><surname>Odnogova</surname><given-names>Z.</given-names></name><name><surname>Kutas</surname><given-names>P.</given-names></name><name><surname>Feckova</surname><given-names>L.</given-names></name><name><surname>Kormanec</surname><given-names>J.</given-names></name></person-group><article-title>Identification and characterization of an indigoidine-like gene for a blue pigment biosynthesis in <italic>Streptomyces aureofaciens</italic> CCM 3239</article-title><source>Folia Microbiol. (Praha)</source><volume>55</volume><year>2010</year><fpage>119</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">20490753</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Olano</surname><given-names>C.</given-names></name><name><surname>Garcia</surname><given-names>I.</given-names></name><name><surname>Gonzalez</surname><given-names>A.</given-names></name><name><surname>Rodriguez</surname><given-names>M.</given-names></name><name><surname>Rozas</surname><given-names>D.</given-names></name><name><surname>Rubio</surname><given-names>J.</given-names></name><name><surname>Sanchez-Hidalgo</surname><given-names>M.</given-names></name><name><surname>Brana</surname><given-names>A.F.</given-names></name><name><surname>Mendez</surname><given-names>C.</given-names></name><name><surname>Salas</surname><given-names>J.A.</given-names></name></person-group><article-title>Activation and identification of five clusters for secondary metabolites in <italic>Streptomyces albus</italic> J1074</article-title><source>Microb. Biotechnol.</source><volume>7</volume><year>2014</year><fpage>242</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">24593309</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Pait</surname><given-names>I.G.U.</given-names></name><name><surname>Kitani</surname><given-names>S.</given-names></name><name><surname>Kurniawan</surname><given-names>Y.N.</given-names></name><name><surname>Asa</surname><given-names>M.</given-names></name><name><surname>Iwai</surname><given-names>T.</given-names></name><name><surname>Ikeda</surname><given-names>H.</given-names></name><name><surname>Nihira</surname><given-names>T.</given-names></name></person-group><article-title>Identification and characterization of lbpA, an indigoidine biosynthetic gene in the gamma-butyrolactone signaling system of <italic>Streptomyces lavendulae</italic> FRI-5</article-title><source>J.&#x000a0;Biosci. Bioeng.</source><volume>124</volume><year>2017</year><fpage>369</fpage><lpage>375</lpage><pub-id pub-id-type="pmid">28533156</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Palmu</surname><given-names>K.</given-names></name><name><surname>Rosenqvist</surname><given-names>P.</given-names></name><name><surname>Thapa</surname><given-names>K.</given-names></name><name><surname>Ilina</surname><given-names>Y.</given-names></name><name><surname>Siitonen</surname><given-names>V.</given-names></name><name><surname>Baral</surname><given-names>B.</given-names></name><name><surname>Makinen</surname><given-names>J.</given-names></name><name><surname>Belogurov</surname><given-names>G.</given-names></name><name><surname>Virta</surname><given-names>P.</given-names></name><name><surname>Niemi</surname><given-names>J.</given-names></name></person-group><article-title>Discovery of the showdomycin gene cluster from <italic>Streptomyces showdoensis</italic> ATCC 15227 yields insight into the biosynthetic logic of <italic>C</italic>-nucleoside antibiotics</article-title><source>ACS Chem. Biol.</source><volume>12</volume><year>2017</year><fpage>1472</fpage><lpage>1477</lpage><pub-id pub-id-type="pmid">28418235</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Preumont</surname><given-names>A.</given-names></name><name><surname>Snoussi</surname><given-names>K.</given-names></name><name><surname>Stroobant</surname><given-names>V.</given-names></name><name><surname>Collet</surname><given-names>J.F.</given-names></name><name><surname>Van Schaftingen</surname><given-names>E.</given-names></name></person-group><article-title>Molecular identification of pseudouridine-metabolizing enzymes</article-title><source>J.&#x000a0;Biol. Chem.</source><volume>283</volume><year>2008</year><fpage>25238</fpage><lpage>25246</lpage><pub-id pub-id-type="pmid">18591240</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Reverchon</surname><given-names>S.</given-names></name><name><surname>Rouanet</surname><given-names>C.</given-names></name><name><surname>Expert</surname><given-names>D.</given-names></name><name><surname>Nasser</surname><given-names>W.</given-names></name></person-group><article-title>Characterization of indigoidine biosynthetic genes in <italic>Erwinia chrysanthemi</italic> and role of this blue pigment in pathogenicity</article-title><source>J.&#x000a0;Bacteriol.</source><volume>184</volume><year>2002</year><fpage>654</fpage><lpage>665</lpage><pub-id pub-id-type="pmid">11790734</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Rezuchova</surname><given-names>B.</given-names></name><name><surname>Homerova</surname><given-names>D.</given-names></name><name><surname>Sevcikova</surname><given-names>B.</given-names></name><name><surname>Nunez</surname><given-names>L.E.</given-names></name><name><surname>Novakova</surname><given-names>R.</given-names></name><name><surname>Feckova</surname><given-names>L.</given-names></name><name><surname>Skultety</surname><given-names>L.</given-names></name><name><surname>Cortes</surname><given-names>J.</given-names></name><name><surname>Kormanec</surname><given-names>J.</given-names></name></person-group><article-title>An efficient blue-white screening system for markerless deletions and stable integrations in <italic>Streptomyces chromosomes</italic> based on the blue pigment indigoidine biosynthetic gene <italic>bpsA</italic></article-title><source>Appl. Microbiol. Biotechnol.</source><volume>102</volume><year>2018</year><fpage>10231</fpage><lpage>10244</lpage><pub-id pub-id-type="pmid">30259098</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>K.</given-names></name><name><surname>Kusakabe</surname><given-names>Y.</given-names></name><name><surname>Esumi</surname><given-names>S.</given-names></name></person-group><article-title>The structure of minimycin, a novel carbon-linked nucleoside antibiotic related to -pseudouridine</article-title><source>J.&#x000a0;Antibiot. (Tokyo)</source><volume>25</volume><year>1972</year><fpage>151</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">5034811</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>V.</given-names></name><name><surname>Brecik</surname><given-names>M.</given-names></name><name><surname>Mukherjee</surname><given-names>R.</given-names></name><name><surname>Evans</surname><given-names>J.C.</given-names></name><name><surname>Svetlikova</surname><given-names>Z.</given-names></name><name><surname>Blasko</surname><given-names>J.</given-names></name><name><surname>Surade</surname><given-names>S.</given-names></name><name><surname>Blackburn</surname><given-names>J.</given-names></name><name><surname>Warner</surname><given-names>D.F.</given-names></name><name><surname>Mikusova</surname><given-names>K.</given-names></name></person-group><article-title>The complex mechanism of antimycobacterial action of 5-fluorouracil</article-title><source>Chem. Biol.</source><volume>22</volume><year>2015</year><fpage>63</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">25544046</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Sosio</surname><given-names>M.</given-names></name><name><surname>Gaspari</surname><given-names>E.</given-names></name><name><surname>Iorio</surname><given-names>M.</given-names></name><name><surname>Pessina</surname><given-names>S.</given-names></name><name><surname>Medema</surname><given-names>M.H.</given-names></name><name><surname>Bernasconi</surname><given-names>A.</given-names></name><name><surname>Simone</surname><given-names>M.</given-names></name><name><surname>Maffioli</surname><given-names>S.I.</given-names></name><name><surname>Ebright</surname><given-names>R.H.</given-names></name><name><surname>Donadio</surname><given-names>S.</given-names></name></person-group><article-title>Analysis of the pseudouridimycin biosynthetic pathway provides insights into the formation of <italic>C</italic>-nucleoside antibiotics</article-title><source>Cell Chem. Biol.</source><volume>25</volume><year>2018</year><fpage>540</fpage><lpage>549.e4</lpage><pub-id pub-id-type="pmid">29551347</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Starr</surname><given-names>M.P.</given-names></name><name><surname>Cosens</surname><given-names>G.</given-names></name><name><surname>Knackmuss</surname><given-names>H.J.</given-names></name></person-group><article-title>Formation of the blue pigment indigoidine by phytopathogenic erwinia</article-title><source>Appl. Microbiol.</source><volume>14</volume><year>1966</year><fpage>870</fpage><lpage>872</lpage><pub-id pub-id-type="pmid">16349687</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Suhadolnik</surname><given-names>R.J.</given-names></name><name><surname>Reichenbach</surname><given-names>N.L.</given-names></name></person-group><article-title>Glutamate as the common precursor for the aglycon of the naturally occurring <italic>C</italic>-nucleoside antibiotics</article-title><source>Biochemistry</source><volume>20</volume><year>1981</year><fpage>7042</fpage><lpage>7046</lpage><pub-id pub-id-type="pmid">6119109</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>H.</given-names></name><name><surname>Kumagai</surname><given-names>T.</given-names></name><name><surname>Kitani</surname><given-names>K.</given-names></name><name><surname>Mori</surname><given-names>M.</given-names></name><name><surname>Matoba</surname><given-names>Y.</given-names></name><name><surname>Sugiyama</surname><given-names>M.</given-names></name></person-group><article-title>Cloning and characterization of a <italic>Streptomyces</italic> single module type non-ribosomal peptide synthetase catalyzing a blue pigment synthesis</article-title><source>J.&#x000a0;Biol. Chem.</source><volume>282</volume><year>2007</year><fpage>9073</fpage><lpage>9081</lpage><pub-id pub-id-type="pmid">17237222</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Tymiak</surname><given-names>A.A.</given-names></name><name><surname>Culver</surname><given-names>C.A.</given-names></name><name><surname>Goodman</surname><given-names>J.F.</given-names></name><name><surname>Seiner</surname><given-names>V.S.</given-names></name><name><surname>Sykes</surname><given-names>R.B.</given-names></name></person-group><article-title>Oxazinomycin produced by a <italic>Pseudomonas</italic> species</article-title><source>J.&#x000a0;Antibiot. (Tokyo)</source><volume>37</volume><year>1984</year><fpage>416</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">6725147</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.A.</given-names></name><name><surname>Ko</surname><given-names>Y.</given-names></name><name><surname>Zeng</surname><given-names>J.</given-names></name><name><surname>Geng</surname><given-names>Y.</given-names></name><name><surname>Ren</surname><given-names>D.</given-names></name><name><surname>Ogasawara</surname><given-names>Y.</given-names></name><name><surname>Irani</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>H.W.</given-names></name></person-group><article-title>Identification of the formycin A biosynthetic gene cluster from <italic>Streptomyces kaniharaensis</italic> illustrates the interplay between biological pyrazolopyrimidine formation and de novo purine biosynthesis</article-title><source>J.&#x000a0;Am. Chem. Soc.</source><volume>141</volume><year>2019</year><fpage>6127</fpage><lpage>6131</lpage><pub-id pub-id-type="pmid">30942582</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Wencewicz</surname><given-names>T.A.</given-names></name></person-group><article-title>Crossroads of antibiotic resistance and biosynthesis</article-title><source>J.&#x000a0;Mol. Biol.</source><volume>431</volume><year>2019</year><fpage>3370</fpage><lpage>3399</lpage><pub-id pub-id-type="pmid">31288031</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Cao</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Qin</surname><given-names>H.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Tao</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name></person-group><article-title>An external substrate-free blue/white screening system in <italic>Escherichia coli</italic></article-title><source>Appl. Microbiol. Biotechnol.</source><volume>101</volume><year>2017</year><fpage>3811</fpage><lpage>3820</lpage><pub-id pub-id-type="pmid">28352998</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Xu</surname><given-names>F.</given-names></name><name><surname>Valiente</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Zhan</surname><given-names>J.</given-names></name></person-group><article-title>An indigoidine biosynthetic gene cluster from <italic>Streptomyces chromofuscus</italic> ATCC 49982 contains an unusual IndB homologue</article-title><source>J.&#x000a0;Ind. Microbiol. Biotechnol.</source><volume>40</volume><year>2013</year><fpage>159</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">23053349</pub-id></element-citation></ref></ref-list><sec id="appsec1"><title>Data and Code Availability</title><p id="p0155">The DNA sequence is deposited in the GenBank database under individual accession numbers MK122964 (for the <italic>min</italic> gene cluster from <italic>S.&#x000a0;hygrocsopicus</italic> JCM 4712) and MN397911 (for the genes <italic>orf3815</italic> and <italic>orf3816</italic> from <italic>S.&#x000a0;hygrocsopicus</italic> JCM 4712).</p></sec><sec id="appsec3" sec-type="supplementary-material"><title>Supplemental Information</title><p id="p0165"><supplementary-material content-type="local-data" id="mmc1"><caption><title>Document S1. Transparent Methods, Figures S1&#x02013;S7, and Tables S1&#x02013;S6</title></caption><media xlink:href="mmc1.pdf"/></supplementary-material></p></sec><ack id="ack0010"><title>Acknowledgments</title><p>We are grateful to Prof. Jixun Zhan (Utah State University, USA) for kindly providing us with related research material. This work was supported by grants <funding-source id="gs4">National Key R &#x00026; D Program of China</funding-source> (2018YFA0903203), the <funding-source id="gs2">National Natural Science Foundation of China</funding-source> (31770041, 31970052), and the foundation of <funding-source id="gs3">Tianjin Engineering Research Center of Microbial Metabolism and Fermentation Process Control</funding-source>, China (ZXKF20180202).</p><sec id="sec4"><title>Author Contributions</title><p id="p0145">L.K., G.X., X.L., J.W., and Z.T. conducted the genetic and biochemical experiments. W.T. helped with the preparation of figures. Y.-S.C. and K.S. analyzed the NMR data. W.C. conceived the project and directed the research. W.C. wrote the manuscript, and Y.Z., Z.D., and N.P.J.P. made a critical reading of the manuscript.</p></sec><sec sec-type="COI-statement" id="sec5"><title>Declaration of Interests</title><p id="p0150">The authors declare no competing interests.</p></sec></ack><fn-group><fn id="appsec2" fn-type="supplementary-material"><p id="p0160">Supplemental Information can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.isci.2019.11.037" id="intref0015">https://doi.org/10.1016/j.isci.2019.11.037</ext-link>.</p></fn></fn-group></back></article>